Global Infertility Testing Market, By Type (Female Infertility Testing, Male Infertility Testing), Test Kits (Follicular Stimulating Hormone (FSH) Urine Test Kits, Luteinizing Hormone (LH) Urine Test Kits, Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits, Others), Prescription Mode (Prescription Based, Over The Counter (OTC) Based), Distribution Channel (Hospitals Pharmacies, Online Pharmacies, Pharmacies & Drug Stores), End Users (Fertility Centres, Hospitals and Clinics, Research Institutes, Cryobanks), Industry Trends and Forecast to 2029
Market Analysis and Insights
Infertility has become a major issue in both developed and developing economies in recent years. Infertility can be caused by a malfunction in either the male or female reproductive systems. Infertility is defined as the inability to become pregnant, maintain a pregnancy, or give birth to a live foetus. Fertilization is the process of increasing the number of sperms that reach the fallopian tubes in order to increase the chances of pregnancy. Intrauterine therapies are a type of fertility treatment that aims to increase the number of sperms entering a woman's uterus in order to increase her chances of becoming pregnant. In most developed economies, intrauterine insemination is a type of minimally invasive technique that is preferred over other fertilisation procedures.
Infertility testing market is expected to gain market growth at a potential rate of 3.2% in the forecast period of 2022 to 2029. Increasing cases of unintended pregnancies will enhance the growth of the market.
Definition
Infertility testing is a battery of tests used to figure out why a woman is unable to conceive. The tests also help determine whether the problem is with the man, the woman, or both. Infertility testing and evaluation are expensive, and the treatment can be uncomfortable at times. Male infertility tests include sperm penetration assays, DNA fragmentation, and oxidative stress analysis, whereas female infertility tests include laparoscopy, ovulation testing, hormone testing, and ovarian reserve testing. Infertility testing is done in research institutes, hospitals, fertility clinics, and clinics.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Female Infertility Testing, Male Infertility Testing), Test Kits (Follicular Stimulating Hormone (FSH) Urine Test Kits, Luteinizing Hormone (LH) Urine Test Kits, Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits, Others), Prescription Mode (Prescription Based, Over The Counter (OTC) Based), Distribution Channel (Hospitals Pharmacies, Online Pharmacies, Pharmacies & Drug Stores), End Users (Fertility Centres, Hospitals and Clinics, Research Institutes, Cryobanks),
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
AB Scientific Ltd. (U.S.), Art Biotech Pvt. Ltd. (India), Cook (U.S.), Dxnow, Inc.(U.S), Eppendorf SE (U.S), Esco Micro Pte. Ltd. (Singapore), Hamilton Thorne, Ltd. (U.S), LabIVF Asia Pte Ltd. (Singapore), Rocket Medical plc (U.K), The Cooper Companies, Inc.(U.S), Vitrolife (Sweden), Irvine Scientific (U.S.), Microptic (U.S), The Cooper Companies Inc. (U.S.)
|
Drivers
-
Rising awareness among population about benefits of testing
Increasing cancer and thyroid occurrences; rising public awareness of the benefits of therapies; and increased investment in the development of advanced and technical solutions are some of the key factors that will drive the growth of the infertility testing market.
-
Increasing government support as well as rise in unplanned pregnancies
The rising rate of unintended pregnancies, supportive government initiatives, and an increasing number of private companies working to prevent unwanted abortions and pregnancies Furthermore, IUD devices are becoming more popular because they are effective, safe, and long-lasting, and they eliminate the need for other contraceptives.
-
Continuous research and development
In the forecast period, increased research activities will create advanced opportunities for the growth of the infertility testing market.
Furthermore, advancement in medical technology, rising initiatives by public and private organizations to spread awareness and growing government funding are the factors that will expand the Infertility testing market. Other factors such as increase in the demand for effective therapies and rising adoption rate for early genetic counselling will positively impact the Infertility testing market's growth rate. Additionally, high disposable income, rising number of cases of seizures and changing lifestyle will result in the expansion of Infertility testing market.
Restraints/Challenges
However, the high cost of treatment and testing, as well as the accuracy issues with testing kits, will impede market growth. The countries' regulatory issues will pose a challenge to the infertility testing market.
This infertility testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on infertility testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Infertility testing Market
Countries all over the world had very little time to prepare for it. According to a UN survey, global lockdown will result in 7 million unwanted pregnancies due to the lack of modern contraceptives and other reproductive healthcare services, including intrauterine devices (IUDs). According to UNICEF, approximately 20 million babies would be born after the countries implemented lockdown. During the pandemic, women should avoid pregnancy not only for personal reasons, but also for public health reasons, though a shortage of Intrauterine therapies and other contraceptive methods has been a major issue.
Recent Developments
- Modern Fertility will launch pregnancy and ovulation tests, as well as a mobile application to centralise all fertility-related data, in June 2020.
- Proov received FDA approval for its at-home ovulation testing kit in March 2020.
Global Infertility testing Market Scope
The infertility testing market is segmented on the basis of type, test kits, prescription mode, distribution channel and end-user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Female infertility testing
- Male infertility testing
The infertility testing market is segmented on the basis of type into female infertility testing and male infertility testing. Female infertility testing has been further sub-segmented into ovulation testing, hysterosalpingography, laparoscopy, transvaginal ultrasound, ovarian reserve testing, hormone testing and others. Male infertility testing has been further sub-segmented into DNA fragmentation, oxidative stress analysis, sperm penetration assay, computer aided semen analysis, sperm agglutination assay, microscopic examination and others.
Test Kits
- Follicular stimulating hormone (FSH) urine test kit
- luteinizing hormone (LH) urine test kits
- human chorionic gonadotropin (HCG) hormone blood test kits
- others
On the basis of test kits, the infertility testing market is segmented into follicular stimulating hormone (FSH) urine test kits, luteinizing hormone (LH) urine test kits, human chorionic gonadotropin (HCG) hormone blood test kits, and others.
Prescription Mode
- Prescription based
- Over the counter (OTC)
On the basis of prescription mode, the infertility testing market is segmented into prescription based and over the counter (OTC) based.
Distribution channel
- Hospital pharmacies
- Online pharmacies
- Drug stores
On the basis of distribution channel, the infertility testing market is segmented into hospitals pharmacies, online pharmacies, pharmacies & drug stores.
End Use
- Hospitals & clinics
- Research institutes
- Cryobanks
On the basis of end-user, the infertility testing market is segmented into fertility centers, hospitals and clinics, research institutes, and cryobanks.
Infertility Testing Market Regional Analysis/Insights
The infertility testing market is analysed and market size insights and trends are provided by country, type, test kits, prescription mode, distribution channel and end-user as referenced above.
The countries covered in the infertility testing market report U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the infertility testing market in terms of market share and revenue, and this dominance is expected to continue during the forecast period. This is due to the region's presence of major key players, well-developed healthcare infrastructure, and high disposable income. Asia-Pacific, on the other hand, is expected to grow at the fastest rate during the forecast period due to increased R&D activities, increased investment in the healthcare sector, and increased government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Infertility Testing Market Share Analysis
The infertility testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to infertility testing market.
Some of the major players operating in the infertility testing market are
- AB Scientific Ltd. (U.S.)
- Art Biotech Pvt. Ltd. (India)
- Cook (U.S.)
- Dxnow, Inc.(U.S)
- Eppendorf SE (U.S)
- Esco Micro Pte. Ltd. (Singapore)
- Hamilton Thorne, Ltd. (U.S)
- LabIVF Asia Pte Ltd. (Singapore)
- Rocket Medical plc (U.K)
- The Cooper Companies, Inc.(U.S)
- Vitrolife (Sweden)
- Irvine Scientific (U.S.)
- Microptic (U.S)
- The Cooper Companies Inc. (U.S.)
SKU-